REFERENCES
- Shetty AK, Kumar A. Osteomyelitis in adolescents. Adolesc Med State Art Rev. 2007;18:79–94.
- Popovich KJ, Hota B, Weinstein RA. Treatment of community-associated methicillin-resistant Staphylococcus aureus. Curr Infect Dis Rep. 2008;10:411–420.
- Fowler VG Jr, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: A consequence of medical progress. JAMA. 2005;293:3012–3021.
- Kielian T, Syed MM, Liu S, et al. The synthetic peroxisome proliferators-activated receptor gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses. J Immunol. 2008;180:5004–5016.
- Gudmundsson OG, Ormerod LD, Kenyon KR, et al. Factors influencing predilection and outcome in bacterial keratitis. Cornea. 1989;8:115–121.
- Friedlin J, Acharya N, Lietman TM, et al. Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. Am J Ophthalmol. 2007;144:313–315.
- Asbell PA, Sahm DF, Shaw M, et al. Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005. J Cataract Refract Surg. 2008;34:814–818.
- Cavuoto K, Zutshi D, Karp CL, et al. Update on bacterial conjunctivitis in South Florida. Ophthalmology. 2008;115:51–56.
- Chisari G. Endophthalmitis: Gram-positive etiological agents and susceptibility to glycopeptides. Curr Clin Pharmacol. 2008;3:153–155.
- Hautala N, Koskela M, Hautala T. Major age group-specific differences in conjunctival bacteria and evolution of antimicrobial resistance revealed by laboratory data surveillance. Curr Eye Res. 2008;33:907–911.
- Lichtenstein SJ, Wagner RS, Jamison T, et al. Speed of bacterial kill with a fluoroquinolone compared with nonfluoroquinolones: Clinical implications and a review of kinetics of kill studies. Adv Ther. 2007;24:1098–1111.
- Denis F, Chaumeil C, Goldschmidt P, et al. Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis. Eur J Ophthalmol. 2008;18:858–868.
- Dorfman MS, Wagner RS, Jamison T, et al. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment. Adv Ther. 2008;25:208–217.
- Granet DB, Dorfman M, Stroman D, et al. A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis. J Pediatr Ophthalmol Strabismus. 2008;45:340–349.
- Behrens-Baumann W, Begall T. Reproducible model of a bacterial conjunctivitis. Ophthalmologica. 1993;206:69–75.
- O’Callaghan R, Callegan M, Moreau J, et al. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun. 1997;65:1571–1578.
- Dajcs J, Austin M, Sloop G, et al. Corneal pathogenesis of Staphylococcus aureus strain Newman. Invest Ophthalmol Vis Sci. 2002;43:1109–1115.
- Sloop GD, Moreau JM, Conerly LL, et al. Acute inflammation of the eyelid and cornea in Staphylococcus keratitis in the rabbit. Invest Ophthalmol Vis Sci. 1999;40:385–391.
- McCormick CC, Balzli CL, Caballero AR, et al. The bactericidal effectiveness of an enhanced tobramycin-dexamethasone formulation. Invest Ophthalmol Vis Sci. 2008;49: ARVO E-Abstract 846.
- Balzli CL, Bartell J, Dajcs J, et al. A highly virulent Staphylococcus aureus: Rabbit anterior chamber infection, characterization, and genetic analysis. Invest Ophthalmol Vis Sci. 2010 May 12. [Epub ahead of print]
- Tang A, Caballero AR, McCormick CC, et al. A new topical model of Staphylococcus aureus keratitis in a scarified rabbit eye. Invest Ophthalmol Vis Sci. 2009;50: ARVO E-Abstract 2397.
- Nwanegbo EC, Romanowski EG, Gordon YJ, et al. Efficacy of topical immunoglobulins against experimental adenoviral ocular infection. Invest Ophthalmol Vis Sci. 2007;48:4171–4176.
- Niederkorn JY. Immune regulatory mechanisms in allergic conjunctivitis: Insights from mouse models. Curr Opin Allergy Clin Immunol. 2008;8:472–476.
- Thomas PB, Zhu Z, Selvam S, et al. Autoimmune dacryoadenitis and keratoconjunctivitis induced in rabbits by subcutaneous injection of autologous lymphocytes activated ex vivo against lacrimal antigens. J Autoimmun. 2008;31:116–122.
- Toma HS, Murina AT, Areaux RG, Jr. et al. Ocular HSV-1 latency, reactivation and recurrent disease. Semin Ophthalmol. 2008;23:249–273.